Skip to content

Investigating the Effect of Licorice Root Capsules on Symptoms of Polycystic Ovary Syndrome

Investigating the Effect of Licorice Root Capsules on Menstrual Pattern and Clinical and Biochemical Signs of Hyperandrogenism in Women with Polycystic Ovary Syndrome

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251101067846N1
Enrollment
70
Registered
2026-02-11
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: Consumers of 500 mg licorice root capsules, one per day for 12 weeks. Intervention 2: Control group: Placebo capsule user, one capsule per day for 12 weeks.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women aged 18-45 Normal TSH levels Polycystic ovary syndrome (based on the Rotterdam criteria) Literate (able to read and write)

Exclusion criteria

Exclusion criteria: Smoking and alcohol addiction Receiving hirsutism treatments such as laser therapy (in the upper lip, chin, and lower abdominal areas) during the past three months. Use of any other hormonal medications during the past three months, based on self-report. Pregnancy and breastfeeding “Presence of other androgenic disorders such as congenital adrenal hyperplasia and androgen-secreting tumors.” Presence of systemic diseases such as cardiovascular, hepatic, renal and endocrine diseases, hypertension, neurosis and mental disorders hyperprolactinemia history of surgery for polycystic ovary syndrome, Allergy to licorice Occurrence of stressful events in the past three months

Design outcomes

Primary

MeasureTime frame
Menstrual cycle. Timepoint: Entry into the study, after one month, after two months, after three months. Method of measurement: Menstrual pattern questionnaire.;Clinical hyperandrogenism. Timepoint: Entry into the study, after one month, after two months, after three months. Method of measurement: Freeman-Galway Scale and Global Acne Severity Scoring System (GAGS) questionnaire.;Biochemical hyperandrogenism. Timepoint: Entry into the study, after three months of intervention. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Hadizadeh Talasaz

Mashhad University of Medical Sciences

hadizadehTF@mums.ac.ir+98 51 3884 6730

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026